Inventor

LEE WEN-HWA

US21 patents

⚠️ This page may combine multiple inventors who share the name “LEE WEN-HWA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEE WEN-HWA

UNIV CALIFORNIA

Genetic mechanisms of tumor suppression

ppRB110 -phosphoprotein the retinoblastoma susceptibility gene product

Products and methods for controlling the suppression of the neoplastic phenotype

Therapeutic use of the retinoblastoma susceptibility gene product

RAD51 inhibitors and uses thereof

Human esterase D, its uses and a process of purification

Method for producing retinoblastoma gene protein products

Retinoblastoma gene-cancer suppressor and regulator

ppRB110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene product

Small molecule modifiers of the HEC1-NEK2 interaction in G2/M

Small molecule modifiers of the Hec1-Nek2 interaction in G2/M

Products and methods for controlling the suppression of the neoplastic phenotype

RAD51 inhibitors and uses thereof

ppRB110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product

LEE WEN-HWA

Compositions and methods for disruption of BRCA2-Rad51 interaction

Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereof

Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases

UNIV TEXAS

Nuclear mitotic phosphoprotein

Antibodies reactive with retinoblastoma binding proteins and methods of using same

ACADEMIA SINICA

Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy

CANJI INC

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells